These findings underscore the potential therapeutic implications of SERMs like Tamoxifen and highlight the importance of understanding ERβ’s function in renal fibrosis for developing targeted treatments for chronic kidney diseases. This evidence concerns the gene ESR2 and chronic kidney disease.